EMA updates GVP - Module III on pharmacovigilance inspections
Revision 2 of GVP Module III – Pharmacovigilance Inspections of the European Medicines Agency (EMA) entered into force on 10 September 2026....
Revision 2 of GVP Module III – Pharmacovigilance Inspections of the European Medicines Agency (EMA) entered into force on 10 September 2026....
Artificial Intelligence (AI) is rapidly becoming an integral part of scientific communication and information processes within the pharmaceutical...
The Ministry of Health has published a new informational note regarding the marketing of injectable fillers, both resorbable and non-resorbable,...
The Ministry of Health has published the National Plan for Official Controls on Biocidal Products – 2026 (PNCB), drafted pursuant to Regulation...
With the European Union's final approval of the new Regulation on Detergents and Surfactants, the sector is embarking on a profound transformation...
Bio Chem s.r.l., as part of its consultancy activity in the chemical-pharmaceutical-healthcare sector, offers client companies, among other...
ECHA has updated the list of suppliers of active substances or the list referred to in Article 95 of Reg. (EU) 528/2012 (BPR).
COMMISSION IMPLEMENTING DECISION (EU) 2024/815 of 6 March 2024 amending Implementing Decision (EU) 2021/1182 as regards harmonized standards for...
Pharmaceutical companies have until February 9, 2025 to update their production systems and adapt to the new regulations.Starting from February 9,...